The nature of peptides presented by an HLA class I low expression allele

Haematologica

Volumn 95, Issue 8, 2010, Pages 1373-1380

  Hinrichs, Jan ^a   Föll, Daniel ^a   Bade Döding, Christina ^a   Huyton, Trevor ^a   Blasczyk, Rainer ^a   Eiz Vesper, Britta ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Hla low expression alleles; Hla A*3014l; Peptide motif; Stem cell transplantation

Indexed keywords

BINDING PROTEIN; CYSTEINE; DISULFIDE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; SERINE;

ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BINDING ASSAY; CELL STRAIN HEK293; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISULFIDE BOND; DONOR SELECTION; ELUTION; EMBRYO; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOBLASTOID CELL LINE; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SUPERNATANT; T LYMPHOCYTE;

ALLELES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; GENE EXPRESSION; HEK293 CELLS; HLA-A ANTIGENS; HUMANS; MASS SPECTROMETRY; MODELS, MOLECULAR; MUTAGENESIS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, PROTEIN;

EID: 77956099705     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.016089     Document Type: Article

References (38)

1. Natarajan K, Li H, Mariuzza RA, Margulies DH. MHC class I molecules, structure and function. Rev Immunogenet. 1999;1(1):32-46.
2. Bade-Doeding C, Elsner HA, Eiz-Vesper B, Seltsam A, Holtkamp U, Blasczyk R. A single amino-acid polymorphism in pocket A of HLA-A 6602 alters the auxiliary anchors compared with HLA-A 6601 ligands. Immunogenetics. 2004;56(2):83-88.
3. Prilliman KR, Jackson KW, Lindsey M, Wang J, Crawford D, Hildebrand WH. HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol. 1999;162(12):7277-7284.
4. Hirv K, Pannicke U, Mytilineos J, Schwarz K. Disulfide bridge disruption in the alpha2 domain of the HLA class I molecule leads to low expression of the corresponding antigen. Hum Immunol. 2006;67(8):589-596.
5. Warburton RJ, Matsui M, Rowland-Jones SL, Gammon MC, Katzenstein GE, Wei T, et al. Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLAA 0201. Effect on maturation and peptide presentation. Hum Immunol. 1994;39(4): 261-271.
6. Hinrichs J, Figueiredo C, Hirv K, Mytilineos J, Blasczyk R, Horn PA, et al. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA. Mol Immunol. 2009;46(7):1451-1457.
7. Oudshoorn M, Horn PA, Tilanus M, Yu N. Typing of potential and selected donors for transplant: methodology and resolution. Tissue Antigens. 2007;69 (Suppl 1):10-2.
8. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3-61.
9. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978;14(1):9-20.
10. Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci. 1993; 9(2):161-167.
11. Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Clin Cancer Res. 1996; 2(1):87-95.
12. Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol. 1993;14(2):94-103.
13. Zeh HJ 3rd, Leder GH, Lotze MT, Salter RD, Tector M, Stuber G, et al. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum Immunol. 1994;39(2):79-86.
14. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991;351(6324):290-296.
15. Lamberth K, Roder G, Harndahl M, Nielsen M, Lundegaard C, Schafer-Nielsen C, et al. The peptide-binding specificity of HLAA 3001 demonstrates membership of the HLA-A3 supertype. Immunogenetics. 2008;60(11):633-643.
16. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 2008;4:2.
17. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom. 1984;11(11):601.
18. Hildebrand WH, Domena JD, Shen SY, Lau M, Terasaki PI, Bunce M, et al. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens. 1994;43(4):209-218.
19. Chelvanayagam G. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics. 1996;45(1):15-26.
20. Wang Q, Canutescu AA, Dunbrack RL Jr. SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling. Nat Protoc. 2008; 3(12):1832-1847.
21. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714-2723.
22. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-763.
23. DeLuca DS, Khattab B, Blasczyk R. A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics. 2007;59(1):25-35.
24. DeLuca DS, Blasczyk R. Implementing the modular MHC model for predicting peptide binding. Methods Mol Biol. 2007;409:261-271.
25. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci. 1999;4: D476-D480.
26. Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 1989;342(6250):692-696.
27. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol. 1991;219(2):277-319.
28. Parker KC, Bednarek MA, Hull LK, Utz U, Cunningham B, Zweerink HJ, et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol. 1992;149(11): 3580-3587.
29. Falk K, Rotzschke O, Takiguchi M, Grahovac B, Gnau V, Stevanovic S, et al. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics. 1994; 40(3):238-241.
30. Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu NZ, et al. Definition of specific peptide motifs for four major HLAA alleles. J Immunol. 1994;152(8):3913-3924.
31. DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol. 1993;151(11):5930-5935.
32. DiBrino M, Parker KC, Shiloach J, Turner RV, Tsuchida T, Garfield M, et al. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol. 1994; 152(2):620-631.
33. Malcherek G, Falk K, Rotzschke O, Rammensee HG, Stevanovic S, Gnau V, et al. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol. 1993; 5(10):1229-1237.
34. Sutton J, Rowland-Jones S, Rosenberg W, Nixon D, Gotch F, Gao XM, et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol. 1993;23(2):447-453.
35. Arnett KL, Huang W, Valiante NM, Barber LD, Parham P. The Bw4/Bw6 difference between HLA-B 0802 and HLA-B 0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics. 1998; 48(1):56-61.
36. Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee HG, Toes RE, et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol. 2000;30(8):2211-2215.
37. Alvarez I, Collado J, Daura X, Colome N, Rodriguez-Garcia M, Gallart T, et al. The rheumatoid arthritis-associated allele HLADR10 (DRB1 1001) shares part of its repertoire with HLA-DR1 (DRB1 0101) and HLA-DR4 (DRB 0401). Arthritis Rheum. 2008;58(6):1630-1639.
38. Wenzel T, Eckerskorn C, Lottspeich F, Baumeister W. Existence of a molecular ruler in proteasomes suggested by analysis of degradation products. FEBS Lett. 1994; 349(2):205-209.